Dr. Xiaowei Su’s research focuses on amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease). He has a specific interest in machine learning techniques using ALS biomarkers to improve predictions for disease progression and survival. He has participated in multicenter collaborations investigating disease biomarkers to better understand ALS pathophysiology.

He is involved in clinical trials investigating new therapies, remote monitoring and quality of life. He recruits for multicenter clinical trials for new treatments in patients with ALS. He has additional training in patient-centered trial design, operations, and analysis through the Penn State Clinical and Translational Sciences Institute initiative sponsored by the National Institutes of Health.

Dr. Su is also interested in the bioethics of care delivery, clinical trials and medical genetics. This research attempts to ensure equitable access to healthcare as well as the availability of new medical advances to the maximum number of individuals who may benefit.

Dr. Xiaowei Su treats a broad spectrum of neuromuscular diseases including motor neuron disorders (ALS); muscle diseases (dystrophies, metabolic muscle disorders, and acquired myopathies); neuromuscular junction disorders (myasthenia gravis); and autoimmune peripheral nerve diseases (Guillain-Barre disease and chronic inflammatory demyelinating polyradiculoneuropathy, CIDP).

Dr. Su works in the Penn State Health Hershey Multidisciplinary ALS Clinic with a team of dedicated ALS nurses, psychologists, speech and respiratory therapists, dietitians, physical and occupational therapists, and social workers to care for the complex needs of patients with ALS.  Dr. Su also diagnoses neuromuscular diseases using electromyography and nerve conduction studies (EMG/NCS). He provides EMG/NCS services at the Penn State Neuroscience Institute clinic in Hershey and at the Penn State Health Camp Hill Specialties clinic in Camp Hill.

Board certification in Electrodiagnostic Medicine, American Board of Electrodiagnostic Medicine (2022)

Board certification in Neuromuscular Medicine, American Board of Psychiatry and Neurology (2022)

Board certification in Neurology, American Board of Psychiatry and Neurology (2020)

Certification in Clinical and Translational Research, Penn State Clinical and Translational Science Institute (2016)